NASDAQ:PSTI
Delisted
Pluristem Therapeutics Stock News
$0.85
+0 (+0%)
At Close: Nov 04, 2022
ARKG: Potential Disruption For Healthcare And Pharma Industries
01:56pm, Tuesday, 19'th Jan 2021
ARKG: Potential Disruption For Healthcare And Pharma Industries
HAIFA, Israel, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic pr
Pluristem Announces DMC Recommendation Following Interim Analysis of its Phase III CLI Study
04:00am, Wednesday, 09'th Dec 2020
HAIFA, Israel, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. ( Nasdaq:PSTI ) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic
Pluristem - Moment Of Truth
09:23am, Tuesday, 08'th Dec 2020
Pluristem's CLI Phase III trial interim results should be published soon. Results are critical and might define the fate of the company.
Pluristem to Present Initial Results from Its Phase I HCT Study with PLX-R18 Demonstrating Safety and Efficacy at the ASH Annual Meeting
07:00am, Wednesday, 18'th Nov 2020
HAIFA, Israel, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. ( Nasdaq:PSTI ) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic
Benzinga's Top Upgrades, Downgrades For June 19, 2020
01:45pm, Friday, 19'th Jun 2020
Upgrades * SunTrust Robinson Humphrey upgraded the stock for EOG Resources Inc (NYSE: EOG) from Hold to Buy. For the first quarter, EOG Resources had an EPS of $0.55, compared to year-ago quarter EP
